2020 临床实践指南:儿童肿瘤和造血干细胞移植受者系统性抗真菌预防治疗

2020-05-27 国外肿瘤科相关专家小组(统称) J Clin Oncol . 2020 May 27.

接受强化骨髓抑制治疗的儿童和青少年以及一些儿童骨髓干细胞移植受者具有较高的侵袭性真菌感染风险,本文由一个国际多学科专家小组共同制定,主要针对儿童肿瘤和造血干细胞移植受者系统性抗真菌预防治疗提供的循证指

中文标题:

2020 临床实践指南:儿童肿瘤和造血干细胞移植受者系统性抗真菌预防治疗

英文标题:

Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients

发布日期:

2020-05-27

简要介绍:

接受强化骨髓抑制治疗的儿童和青少年以及一些儿童骨髓干细胞移植受者具有较高的侵袭性真菌感染风险,本文由一个国际多学科专家小组共同制定,主要针对儿童肿瘤和造血干细胞移植受者系统性抗真菌预防治疗提供的循证指导。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 临床实践指南:儿童肿瘤和造血干细胞移植受者系统性抗真菌预防治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f2ddb1c001913627, title=2020 临床实践指南:儿童肿瘤和造血干细胞移植受者系统性抗真菌预防治疗, enTitle=Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients, guiderFrom=J Clin Oncol . 2020 May 27., authorId=0, author=, summary=接受强化骨髓抑制治疗的儿童和青少年以及一些儿童骨髓干细胞移植受者具有较高的侵袭性真菌感染风险,本文由一个国际多学科专家小组共同制定,主要针对儿童肿瘤和造血干细胞移植受者系统性抗真菌预防治疗提供的循证指, cover=https://img.medsci.cn/2020531/1590865204477_2020535.jpg, journalId=0, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Wed May 27 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>接受强化骨髓抑制治疗的儿童和青少年以及一些儿童骨髓干细胞移植受者具有较高的侵袭性真菌感染风险,本文由一个国际多学科专家小组共同制定,主要针对儿童肿瘤和造血干细胞移植受者系统性抗真菌预防治疗提供的循证指导。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=8486, tagName=造血干细胞移植)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=8486, guiderKeyword=造血干细胞移植, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4059, appHits=220, showAppHits=0, pcHits=1016, showPcHits=3839, likes=3, shares=15, comments=17, approvalStatus=1, publishedTime=Sun May 31 03:05:06 CST 2020, publishedTimeString=2020-05-27, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Sun May 31 03:00:10 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Thu Jan 04 00:52:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 临床实践指南:儿童肿瘤和造血干细胞移植受者系统性抗真菌预防治疗.pdf)])
2020 临床实践指南:儿童肿瘤和造血干细胞移植受者系统性抗真菌预防治疗.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1011522, encodeId=f1a310115224c, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKqQKhM8NKj1ibN9IcWzNpffJo47oAHKVh1Jgm0OmfQ51VeBxLccTAjd1DKW0h1rT7ia4eAgbLKUFNQ/132, createdBy=13662539060, createdName=ms3780456291307188, createdTime=Wed Aug 25 22:51:18 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976104, encodeId=cf859e610450, content=梅斯医学很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Jun 23 10:32:32 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957709, encodeId=01f195e709bb, content=想报考下内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9325480217, createdName=ms3000001062600620, createdTime=Fri Apr 16 21:40:08 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957708, encodeId=e3c195e708c2, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9325480217, createdName=ms3000001062600620, createdTime=Fri Apr 16 21:39:48 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925410, encodeId=0a1692541028, content=腻害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12ec5444496, createdName=ms2000000481720009, createdTime=Fri Feb 19 08:59:17 CST 2021, time=2021-02-19, status=1, ipAttribution=)]
    2021-08-25 ms3780456291307188

    点赞

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1011522, encodeId=f1a310115224c, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKqQKhM8NKj1ibN9IcWzNpffJo47oAHKVh1Jgm0OmfQ51VeBxLccTAjd1DKW0h1rT7ia4eAgbLKUFNQ/132, createdBy=13662539060, createdName=ms3780456291307188, createdTime=Wed Aug 25 22:51:18 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976104, encodeId=cf859e610450, content=梅斯医学很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Jun 23 10:32:32 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957709, encodeId=01f195e709bb, content=想报考下内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9325480217, createdName=ms3000001062600620, createdTime=Fri Apr 16 21:40:08 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957708, encodeId=e3c195e708c2, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9325480217, createdName=ms3000001062600620, createdTime=Fri Apr 16 21:39:48 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925410, encodeId=0a1692541028, content=腻害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12ec5444496, createdName=ms2000000481720009, createdTime=Fri Feb 19 08:59:17 CST 2021, time=2021-02-19, status=1, ipAttribution=)]
    2021-06-23 湘雅科教

    梅斯医学很赞

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1011522, encodeId=f1a310115224c, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKqQKhM8NKj1ibN9IcWzNpffJo47oAHKVh1Jgm0OmfQ51VeBxLccTAjd1DKW0h1rT7ia4eAgbLKUFNQ/132, createdBy=13662539060, createdName=ms3780456291307188, createdTime=Wed Aug 25 22:51:18 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976104, encodeId=cf859e610450, content=梅斯医学很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Jun 23 10:32:32 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957709, encodeId=01f195e709bb, content=想报考下内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9325480217, createdName=ms3000001062600620, createdTime=Fri Apr 16 21:40:08 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957708, encodeId=e3c195e708c2, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9325480217, createdName=ms3000001062600620, createdTime=Fri Apr 16 21:39:48 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925410, encodeId=0a1692541028, content=腻害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12ec5444496, createdName=ms2000000481720009, createdTime=Fri Feb 19 08:59:17 CST 2021, time=2021-02-19, status=1, ipAttribution=)]
    2021-04-16 ms3000001062600620

    想报考下内容

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1011522, encodeId=f1a310115224c, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKqQKhM8NKj1ibN9IcWzNpffJo47oAHKVh1Jgm0OmfQ51VeBxLccTAjd1DKW0h1rT7ia4eAgbLKUFNQ/132, createdBy=13662539060, createdName=ms3780456291307188, createdTime=Wed Aug 25 22:51:18 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976104, encodeId=cf859e610450, content=梅斯医学很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Jun 23 10:32:32 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957709, encodeId=01f195e709bb, content=想报考下内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9325480217, createdName=ms3000001062600620, createdTime=Fri Apr 16 21:40:08 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957708, encodeId=e3c195e708c2, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9325480217, createdName=ms3000001062600620, createdTime=Fri Apr 16 21:39:48 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925410, encodeId=0a1692541028, content=腻害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12ec5444496, createdName=ms2000000481720009, createdTime=Fri Feb 19 08:59:17 CST 2021, time=2021-02-19, status=1, ipAttribution=)]
    2021-04-16 ms3000001062600620

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1011522, encodeId=f1a310115224c, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKqQKhM8NKj1ibN9IcWzNpffJo47oAHKVh1Jgm0OmfQ51VeBxLccTAjd1DKW0h1rT7ia4eAgbLKUFNQ/132, createdBy=13662539060, createdName=ms3780456291307188, createdTime=Wed Aug 25 22:51:18 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976104, encodeId=cf859e610450, content=梅斯医学很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Jun 23 10:32:32 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957709, encodeId=01f195e709bb, content=想报考下内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9325480217, createdName=ms3000001062600620, createdTime=Fri Apr 16 21:40:08 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957708, encodeId=e3c195e708c2, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9325480217, createdName=ms3000001062600620, createdTime=Fri Apr 16 21:39:48 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925410, encodeId=0a1692541028, content=腻害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12ec5444496, createdName=ms2000000481720009, createdTime=Fri Feb 19 08:59:17 CST 2021, time=2021-02-19, status=1, ipAttribution=)]
    2021-02-19 ms2000000481720009

    腻害了

    0

拓展阅读

2015 ASBMT指南:造血干细胞移植治疗多发性骨髓瘤

美国血液与骨髓移植学会(ASBMT,American Society for Blood and Marrow Transplantation) · 2015-03-10

2016 ECIL-5建议:血液恶性肿瘤以及接受造血干细胞移植患者病毒性肝炎的管理

欧洲白血病感染会议(ECIL,European Conference on Infections in Leukaemia) · 2016-05-01

2018 EBMT立场声明:造血干细胞移植后患者腺病毒感染的管理

欧洲血液和骨髓移植小组(EBMT,European Group for Blood and Marrow Transplantation) · 2018-04-16